Status:
UNKNOWN
Pathological Fracture in Potentially Unstable Spinal Metastases of Breast Cancer
Lead Sponsor:
Ruijin Hospital
Conditions:
Spinal Metastases
Breast Cancer
Eligibility:
FEMALE
18-65 years
Brief Summary
The purpose of this study is to identify potential risk factors for and determine the rate of pathological fracture for patients which having spine metastases from breast cancer and be defined as pote...
Detailed Description
Considering the concept of spinal instability remains important in the clinical decision-making process for patients with spine metastases, the Spine Oncology Study Group (SOSG) devised an 18-point SI...
Eligibility Criteria
Inclusion
- Age 18-65 years, female
- Had a histological confirmation of breast cancer, including all pathological types
- Had a histological or radiological confirmation of spinal metastases from breast cancer
- SINS 7-12
Exclusion
- Prior prophylactic stabilization surgery to the spine at current level of interest
- Patients with other malignancies except breast cancer
- Misdiagnosis of spinal metastases from breast cancer confirmed by pathological examination
- Patients without undergoing follow-up on schedule
- Withdraw from the study for any reason
Key Trial Info
Start Date :
December 15 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 15 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03365973
Start Date
December 15 2017
End Date
December 15 2022
Last Update
October 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China, 200025